Skip to main content

Table 2 Rates of Prescribing ChEIs and Memantine

From: Clinicians’ prescription preferences for treating patients with Alzheimer’s disease in Shanghai

Drug Characteristics Psychiatrists (n = 39) Neurologists (n = 66) General physicians (n = 43) F/X 2 P value
ChEIs, n (%) 37(94.9) 65(98.5) 41(95.2) 1.605 0.601
Donepezil, n (%) 20(51.3) 60(90.9) 21(48.8) 28.295 0.000
Dose (mg/day), mean(SD) 5.75 ± 1.832 5.67 ± 1.714 5.24 ± 1.091 0.651 0.524
Rivastigmine, n (%) 1(2.6) 18(27.3) 4(9.3) 13.200 0.001
Dose (mg/day), mean(SD) 6.00 ± 0.000 5.83 ± 2.515 5.25 ± 2.872 0.090 0.915
Galanthamine, n (%) 7(17.9) 11(16.7) 1(2.3) 6.022 0.049
Dose (mg/day), mean(SD) 15.43 ± 2.760 14.91 ± 4.764 12.00 ± 0.000 0.303 0.743
Huperzine A, n (%) 34(87.2) 45(68.2) 28(65.1) 5.978 0.050
Dose (ug/day), mean(SD) 280.88 ± 81.66 263.33 ± 89.443 278.57 ± 95.674 0.456 0.635
Memantine, n(%) 8(20.5) 39(59.1) 9(20.9) 22.878 0.000
Dose (mg/day), mean(SD) 11.88 ± 4.581 11.15 ± 4.209 11.67 ± 2.500 0.140 0.870